13F Data
13F filer · CIK 1601086

ARMISTICE CAPITAL, LLC

NEW YORK, NY · filing since Q4 2014 · last filing Aug 14, 2026
Reported value
$8.2B
+$2.5B vs prior
Positions
333
New / sold out
172 / 100
Added / reduced
73 / 68
Turnover
15.2%
buys $2.5B · sells $1.0B
Top-10 weight
61.5%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedSPYSTATE STR SPDR S&P 500 ETF TPUT+1,100,000+52.4%+$821.4M
AddedISHARES TRPUT+2,300,000+65.7%+$691.0M
AddedCYTOKINETICS INC+436,804+57.1%+$37.2M
AddedSUPERNUS PHARMACEUTICALS+750,854+39.6%+$34.9M
AddedREGENERON PHARMACEUTICALS+53,683+148.6%+$33.5M
AddedSANOFI SA+764,000+254.7%+$32.6M
NewTRAVERE THERAPEUTICS INCCALL+500,000–+$28.4M
NewWATERS CORP+75,004–+$28.1M
NewMINERALYS THERAPEUTICS INCCALL+1,040,000–+$28.1M
AddedINCYTE CORP+243,188+37.0%+$27.6M
235 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedTRAVERE THERAPEUTICS INC-3,324,878-67.9%$-188.9M
ReducedPTC THERAPEUTICS INC-1,003,054-48.4%$-81.8M
ReducedIMMUNOVANT INC-1,828,916-51.3%$-70.5M
ReducedDATADOG INC-170,885-81.9%$-44.5M
ReducedNEUROCRINE BIOSCIENCES INC-188,162-26.0%$-31.7M
Sold outAVANOS MED INC-2,000,000-100.0%$-28.0M
ReducedHUMANA INC-68,752-48.7%$-27.3M
ReducedIMMUNOVANT INCCALL-700,000-36.8%$-27.0M
Sold outMEDLINE INC-564,857-100.0%$-25.1M
Sold outKALVISTA PHARMACEUTICALS INC-1,236,000-100.0%$-24.9M
158 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2014: $208.1MQ1 2015: $225.6MQ2 2015: $278.4MQ3 2015: $292.8MQ4 2015: $280.2MQ1 2016: $254.8MQ2 2016: $262.7MQ3 2016: $311.6MQ4 2016: $422.7MQ1 2017: $484.3MQ2 2017: $784.7MQ3 2017: $848.9MQ4 2017: $1.0BQ1 2018: $1.3BQ2 2018: $1.5BQ3 2018: $1.7BQ4 2018: $1.3BQ1 2019: $1.8BQ2 2019: $1.6BQ3 2019: $1.1BQ4 2019: $1.3BQ1 2020: $1.4BQ2 2020: $1.9BQ3 2020: $2.2BQ4 2020: $2.2BQ1 2021: $4.4BQ2 2021: $3.8BQ3 2021: $4.1BQ4 2021: $4.1BQ1 2022: $3.5BQ2 2022: $3.9BQ3 2022: $5.8BQ4 2022: $5.7BQ1 2023: $6.9BQ2 2023: $6.9BQ3 2023: $6.5BQ4 2023: $7.3BQ1 2024: $7.5BQ2 2024: $7.9BQ3 2024: $6.3BQ4 2024: $7.3BQ1 2025: $6.7BQ2 2025: $5.8BQ3 2025: $6.7BQ4 2025: $8.4BQ1 2026: $5.6BQ2 2026: $8.2B
Q4 2014Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1SPYSTATE STR SPDR S&P 500 ETF TPUT3,200,000$2.4B29.24%
2ISHARES TRPUTRUSSELL 2000 ETF5,800,000$1.7B21.32%
3MADRIGAL PHARMACEUTICALS INCCOM288,000$154.6M1.89%
4CYTOKINETICS INCCALLCOM NEW1,530,000$130.3M1.59%
5SUPERNUS PHARMACEUTICALSCOM2,646,201$123.1M1.51%
6AGIOS PHARMACEUTICALS INCCALLCOM2,810,000$104.3M1.28%
7CYTOKINETICS INCCOM NEW1,201,342$102.3M1.25%
8INCYTE CORPCOM900,005$102.0M1.25%
9NEUROCRINE BIOSCIENCES INCCOM535,838$90.3M1.10%
10TRAVERE THERAPEUTICS INCCOM1,572,539$89.3M1.09%
323 more rows. Subscribe for $29/month to see every row, download the data and use the API.
ARMISTICE CAPITAL, LLC 13F holdings · 13F Data